ROGERS MICHAEL W

Executive Vice President at Endo Pharmaceuticals Solutions Inc. · on record since Feb 21, 2006
Director at EyePoint, Inc. · on record since Aug 27, 2007
Director at SAJAN INC · on record since Feb 25, 2010
EVP, CFO and Treasurer at BG Medicine, Inc. · on record since Feb 3, 2011
Director at Fortress Biotech, Inc. · on record since Sep 13, 2011
Chief Financial Officer at Acorda Therapeutics, Inc. · on record since Oct 9, 2013
Director at KERYX BIOPHARMACEUTICALS INC · on record since May 27, 2016
Director at Akebia Therapeutics, Inc. · on record since Dec 13, 2018
See Remarks at Whitehawk Therapeutics, Inc. · on record since May 16, 2019
Director at Aravive, Inc. · on record since Sep 17, 2020

Insider trading activity of ROGERS MICHAEL W

Transactions on record: 130; since Oct 2, 2003

Open-market buys: 3; $56K

Open-market sells: 5; $405.9K

Companies traded: 10; last filing Jun 22, 2026

Figures computed from official regulatory filings — .

Companies where ROGERS MICHAEL W has traded

Akebia Therapeutics, Inc.16 tx · Jun 22, 2026
Aravive, Inc.4 tx · Sep 26, 2022
EyePoint, Inc.21 tx · $113K · Jun 27, 2019
Whitehawk Therapeutics, Inc.5 tx · $1.6M · May 16, 2019
KERYX BIOPHARMACEUTICALS INC8 tx · Dec 13, 2018
27 tx · $155.3K · Jul 19, 2017
14 tx · $405.9K · May 13, 2016
2 tx · Feb 11, 2013
2 tx · Feb 24, 2012
31 tx · $469K · Feb 25, 2009

Track record of ROGERS MICHAEL W

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ROGERS MICHAEL W

Co-insiders of ROGERS MICHAEL W

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
Akebia Therapeutics, Inc.Listing on record	Jun 22, 2026	AwardD (derivative)	53,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 22, 2026	Award	35,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 11, 2025	Award	35,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 11, 2025	AwardD (derivative)	53,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	45,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2024	Award	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 8, 2023	Award	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 8, 2023	AwardD (derivative)	45,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 26, 2022	AwardD (derivative)	97,063	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2022	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2022	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 13, 2021	AwardD (derivative)	22,812	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 3, 2021	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 3, 2021	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 17, 2020	AwardD (derivative)	14,987	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 17, 2020	AwardD (derivative)	15,024	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2020	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2020	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 27, 2019	AwardD (derivative)	40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 24, 2019	ExerciseD (derivative)	-6,667	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 24, 2019	Exercise	6,667	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Whitehawk Therapeutics, Inc.Listing unverified	May 16, 2019	AwardD (derivative)	430,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Whitehawk Therapeutics, Inc.Listing unverified	May 16, 2019	AwardD (derivative)	169,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
Akebia Therapeutics, Inc.Listing on record	Jun 22, 2026	AwardD (derivative)	53,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 22, 2026	Award	35,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 11, 2025	Award	35,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 11, 2025	AwardD (derivative)	53,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	45,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2024	Award	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 8, 2023	Award	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 8, 2023	AwardD (derivative)	45,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 26, 2022	AwardD (derivative)	97,063	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2022	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2022	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 13, 2021	AwardD (derivative)	22,812	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 3, 2021	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 3, 2021	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 17, 2020	AwardD (derivative)	14,987	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aravive, Inc.Listing unverified	Sep 17, 2020	AwardD (derivative)	15,024	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2020	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 9, 2020	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 27, 2019	AwardD (derivative)	40,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 24, 2019	ExerciseD (derivative)	-6,667	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
EyePoint, Inc.Listing on record	Jun 24, 2019	Exercise	6,667	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	AwardD (derivative)	20,100	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	Award	13,700	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Whitehawk Therapeutics, Inc.Listing unverified	May 16, 2019	AwardD (derivative)	430,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Whitehawk Therapeutics, Inc.Listing unverified	May 16, 2019	AwardD (derivative)	169,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC